Frontotemporal Dementia clinical trials
29 active trials name this condition. Describe your situation to see which ones you may be eligible for.
Refine by biomarker
By location
- A Study to Evaluate the Safety and Effect of AVB-101, a Gene Therapy Product, in Subjects With a Genetic Sub-type of Frontotemporal Dementia (FTD-GRN)
- Vortioxetine for the Treatment of Mood and Cognitive Symptoms in Frontotemporal Dementia
- Neurologic Stem Cell Treatment Study
- First-in-Human Evaluation of an Astrocytic Glutamate Transporter (EAAT2) PET Tracer in Dementia
- CW2IP2: Imaging and Diagnostic Assessments
- PET Imaging of Cyclooxygenases in Neurodegenerative Brain Disease
- Low-Dose Radiotherapy for Alzheimer's Disease
- Biospecimen Biorepository for the Study of ALS, ALS-FTD and Similar Neurodegenerative Disorders
- Late Onset Alzheimer's Disease
- Clinical Procedures to Support Research in ALS
- NYSCF Scientific Discovery Biobank
- ARTFL LEFFTDS Longitudinal Frontotemporal Lobar Degeneration (ALLFTD)
- Longitudinal Cognitive Assessment by BoCA
- DC Longitudinal Study on Aging and Specimen Bank
- Retinal Imaging in Neurodegenerative Disease
- Investigating Complex Neurodegenerative Disorders Related to Amyotrophic Lateral Sclerosis and Frontotemporal Dementia
- Characterization of Inclusion Body Myopathy Associated With Paget's Disease of Bone and Frontotemporal Dementia (IBMPFD)
- Language in Primary Progressive Aphasia
- STELLA-FTD: Examination of a Behavior Change Intervention for FTD Family Care Partners
- Characterization of the Serotonin 2A Receptor Selective PET Tracer [18F]MH.MZ in Patients With Neurodegenerative Diseases
- Using the EHR to Advance Genomic Medicine Across a Diverse Health System
- Neuromodulation for Behavioral Changes in Neurological Disorders
- A Wearable Sensor Platform for Remote Monitoring of Individuals on the Frontotemporal Dementia Spectrum
- Clinico-Pathologic-Genetic-Imaging Study of Neurodegenerative and Related Disorders
- Speech-Language Treatment With Remotely Supervised Transcranial Direct Current Stimulation in Primary Progressive Aphasia
- Imaging of Brain Amyloid Plaques in the Aging Population
- Research Study for Patients With Neurological Diseases Which Evaluates the Patient Experience of the MemorEM Device
- Pilot Trial Evaluating Patient Experience With the MemorEM for Patients With Neurological Diseases
- A Study of PBFT02 in Participants With FTD and Mutations in the Granulin Precursor (GRN) or C9ORF72 Genes
Guides for people searching for a trial
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.
Showing active trials that list “Frontotemporal Dementia” as a condition. Eligibility shown on each trial is an estimate — the trial's study team makes the final decision.